CRP and COVID-19: CRP-levels were elevated (> 5 mg/l) at baseline in COVID-19 (9/13 patients (69%)), and non-COVID-19 (9/15 patients (60%)) group, and partly on discharge (COVID-19: 5/15 (33%), Non-COVID-19: 8/12 (67%)).